Type to search

Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases | Pharmtech Focus
Amgen Announces Tezepelumab Biologics License Application Submitted To U.S. FDA | Pharmtech Focus